1. Home
  2. RUN vs HAE Comparison

RUN vs HAE Comparison

Compare RUN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrun Inc.

RUN

Sunrun Inc.

HOLD

Current Price

$17.91

Market Cap

4.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$83.09

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUN
HAE
Founded
2007
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2015
1991

Fundamental Metrics

Financial Performance
Metric
RUN
HAE
Price
$17.91
$83.09
Analyst Decision
Buy
Buy
Analyst Count
18
9
Target Price
$20.63
$84.38
AVG Volume (30 Days)
7.1M
854.6K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.54
EPS
N/A
3.44
Revenue
$2,316,656,000.00
$1,327,850,000.00
Revenue This Year
$18.66
N/A
Revenue Next Year
$6.33
$6.01
P/E Ratio
N/A
$24.30
Revenue Growth
13.79
N/A
52 Week Low
$5.38
$47.32
52 Week High
$22.44
$87.32

Technical Indicators

Market Signals
Indicator
RUN
HAE
Relative Strength Index (RSI) 46.24 70.71
Support Level $17.47 $82.30
Resistance Level $18.91 $87.32
Average True Range (ATR) 1.02 2.20
MACD -0.01 -0.56
Stochastic Oscillator 20.10 61.70

Price Performance

Historical Comparison
RUN
HAE

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: